Apeiron Ria LLC Heron Therapeutics, Inc. Transaction History
Apeiron Ria LLC
- $322 Million
- Q2 2024
A detailed history of Apeiron Ria LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Apeiron Ria LLC holds 188,635 shares of HRTX stock, worth $390,474. This represents 0.21% of its overall portfolio holdings.
Number of Shares
188,635
Previous 124,000
52.13%
Holding current value
$390,474
Previous $343,000
92.42%
% of portfolio
0.21%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding HRTX
# of Institutions
198Shares Held
129MCall Options Held
94.7KPut Options Held
148K-
Rubric Capital Management LP New York, NY26.7MShares$55.3 Million2.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$17.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$17.2 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.6MShares$15.7 Million0.05% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$14.5 Million58.47% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $246M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...